Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation

COVID-19 continues to exact a toll on human health despite the availability of several vaccines. Bacillus Calmette Guérin (BCG) has been shown to confer heterologous immune protection against viral infections including COVID-19 and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here we test...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Alok K., Wang, Rulin, Lombardo, Kara A., Praharaj, Monali, Bullen, C. Korin, Um, Peter, Davis, Stephanie, Komm, Oliver, Illei, Peter B., Ordonez, Alvaro A., Bahr, Melissa, Huang, Joy, Gupta, Anuj, Psoter, Kevin J., Jain, Sanjay K., Bivalacqua, Trinity J., Yegnasubramanian, Srinivasan, Bishai, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936112/
https://www.ncbi.nlm.nih.gov/pubmed/35313583
http://dx.doi.org/10.1101/2022.03.15.484018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936112/
https://www.ncbi.nlm.nih.gov/pubmed/35313583
http://dx.doi.org/10.1101/2022.03.15.484018

Ejemplares similares